Periconceptional vitamin use and leukemia risk in children with Down syndrome: A children's oncology group study

Cancer

Volumn 104, Issue 2, 2005, Pages 405-410

  Ross, Julie A ^a,b   Blair, Cindy K ^a,b   Olshan, Andrew F ^c   Robison, Leslie L ^a,b   Smith, Franklin O ^d   Heerema, Nyla A ^e   Roesler, Michelle ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c IL   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Children; Down syndrome; Epidemiology; Leukemia; Vitamin supplementation

Indexed keywords

VITAMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CLASSIFICATION; CANCER PREVENTION; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CONCEPTION; CONTROLLED STUDY; DOWN SYNDROME; EVIDENCE BASED MEDICINE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; RISK REDUCTION; VITAMIN SUPPLEMENTATION; ACUTE LYMPHOCYTIC LEUKEMIA; CASE CONTROL STUDY; DIET SUPPLEMENTATION; INFANT; MATERNAL CARE; MYELOID LEUKEMIA; NEWBORN; PRESCHOOL CHILD; RISK;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; DOWN SYNDROME; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; PRECONCEPTION CARE; PREGNANCY; RISK; VITAMINS;

EID: 22244448021     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21171     Document Type: Article

References (36)

1. Fong CT, Brodeur GM. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet Cytogenet. 1987;28:55-76.
2. Sakurai M, Swansbury GJ. Fourth international workshop on chromosomes in leukemia 1982: overview of association between chromosome pattern and cell morphology, age, sex, and race. Cancer Genet Cytogenet. 1984;11:265-274.
3. Ross JA. Epidemiologie studies of childhood leukemia: where do we go from here? Med Pediatr Oncol. 1999;32:65-67.
4. Ross JA, Spector LG, Robison LL, Olshan AF. Epidemiology of leukemia in children with Down syndrome. Pediatr Blood Cancer. 2004;43:1-5.
5. Greaves MF. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia. 1988;2:120-125.
6. Stevenson RE, Allen WP, Pai GS, et al. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics. 2000;106:677-683.
7. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med. 1999;341:1509-1519.
8. Wen W, Shu XO, Potter JD, et al. Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer. 2002;95:1786-1794.
9. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet. 2001;358:1935-1940.
10. Ross JA, Severson RK, Pollock BH, Robison LL. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer. 1996;77:201-207.
11. Liu L, Krailo M, Reaman GH, Bernstein L. Childhood cancer patients' access to cooperative group cancer programs: a population-based study. Cancer. 2003;97:1339-1345.
12. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet. 1995;346:393-396.
13. Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA. Multivitamin supplementation and risk of birth defects. Am J Epidemiol. 1999;150:675-682.
14. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet. 2004;125C:12-21.
15. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137.
16. Olshan AF, Smith JC, Bondy ML, Neglia JP, Pollock BH. Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology. 2002;13:575-580.
17. Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol. 1996;143:996-1001.
18. Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med. 1993;329:536-541.
19. Preston-Martin S, Pogoda JM, Mueller BA, et al. Prenatal vitamin supplementation and risk of childhood brain tumors. Int J Cancer Suppl. 1998;11:17-22.
20. van Poppel G, van den Berg H. Vitamins and cancer. Cancer Lett. 1997;114:195-202.
21. Kim YI, Pogribny IP, Basnakian AG, et al. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr. 1997;65:46-52.
22. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev. 2004;13:511-519.
23. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem. 1999;10:66-88.
24. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA. 2001;98: 4004-4009.
25. Franco RF, Simoes BP, Tone LG, Gabellini SM, Zago MA, Falcao RP. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 2001;115:616-618.
26. Krajinovic M, Lamothe S, Labuda D, et al. Role of MTHFR polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood. 2004;103:252-257.
27. Stuppia L, Gatta V, Gaspari AR, et al. C677T mutation in the 5,10-MTHFR gene and risk of Down syndrome in Italy. Eur J Hum Genet. 2002;10:388-390.
28. James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr. 1999;70:495-501.
29. Boduroglu K, Alanay Y, Koldan B, Tuncbilek E. Methylenetetrahydrofolate reductase enzyme polymorphisms as maternal risk for Down syndrome among Turkish women. Am J Med Genet. 2004;127A:5-10.
30. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12: 461-466.
31. Wiemels JL, Cazzaniga G, Daniotti M, et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet. 1999;354:1499-1503.
32. Potter JD. Chemoprevention: pharmacology or biology? Oncology. 1996;10:1487-1488.
33. Rossig L, Hoffmann J, Hugel B, et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation. 2001;104:2182-2187.
34. Fenech M, Ferguson LR. Vitamins/minerals and genomic stability in humans. Mutat Res. 2001;475:1-6.
35. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241-251.
36. Williams LM, Morrow B, Lansky A, et al. Surveillance for selected maternal behaviors and experiences before, during, and after pregnancy. Pregnancy Risk Assessment Monitoring System (PRAMS), 2000. MMWR Surveill Summ. 2003;52:1-14.